Key result
HeartWare was associated with a greater incidence of stroke compared to HeartMate II, identified using a modified likelihood ratio test incorporating exposure-time.
Why the study?
Many current statistical methods for safety signal detection in medical devices do not control for type I error when assessing multiple device and adverse event combinations, leading to increased false signals and the need for more robust methods.
Does HeartWare LVAD compared to HeartMate II LVAD increase the risk of adverse events such as stroke in patients with chronic, advanced left ventricular failure?
Observational
Does HeartWare LVAD compared to HeartMate II LVAD increase the risk of adverse events such as stroke in patients with chronic, advanced left ventricular failure?
Answers are grounded in this paper and cite their sources.
A modified likelihood ratio test effectively identified a higher incidence of stroke with HeartWare compared to HeartMate II LVADs, demonstrating its utility for post-market safety surveillance.
Effective post-market safety surveillance of medical devices is critical for public health. However, many current statistical methods for safety signal detection do not control for type I error when assessing multiple device and adverse event (AE) combinations. This can result in increased false signals, underscoring the need for more robust statistical methods. Moreover, the duration of medical device use can be an important factor to consider in safety surveillance. In this study, we adapted a likelihood ratio test (LRT) based method, which was initially developed and applied to drugs, to identify safety signals for left ventricular assist devices (LVAD). Among patients with chronic, advanced left ventricular failure, we analyzed AE data for HeartWare and HeartMate II patients during a two-year period and further incorporated person-years (henceforth exposure-time). The novel modified LRT and conventional Z-test with p-values adjusted by the Benjamini-Hochberg (BH) procedure were used to explore safety signals by comparing HeartWare and HeartMate II patients in the presence of multiple adverse events. Both methods identified greater incidence of stroke among HeartWare as compared to HeartMate II patients without exposure-time (p = .025 for LRT and p = .027 for Z-test with BH) and with exposure-time (p = .002 for LRT and p = .005 for Z-test with BH). By using improved statistical methods for safety signal detection, potential safety issues can be identified and addressed in a more timely manner to enhance public safety.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2020) conducted an observational in chronic, advanced left ventricular failure. HeartWare vs. HeartMate II was evaluated on stroke (p=0.002). HeartWare was associated with a greater incidence of stroke compared to HeartMate II, identified using a modified likelihood ratio test incorporating exposure-time.
Synapse has enriched 10 related papers. Consider them for comparative context: